A Study of Enzastaurin in Patients With Leukemia

Clinical trial NCT00452257 · COMPLETED

Trial details

NCT number: NCT00452257
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia, Lymphocytic

Start date: 2007-05-01
Primary completion: 2008-09-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.